Stamford, CT -- (SBWIRE) -- 01/23/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Brainstorm Cell Therapeutics Inc(OTCBB:BCLI), Overseas Shipholding Group Inc.(OTCMKTS:OSGIQ), IntelGenx Technologies Corp.(OTCMKTS:IGXT), Titan Pharmaceuticals, Inc.(OTCBB:TTNP)
Brainstorm Cell Therapeutics Inc(OTCBB:BCLI) opened the session at $0.28, remained amid the day range of $0.28 - $0.32, and closed the session at $0.300. The stock showed a positive performance of +10.29% in previous trading session. The stock gained a volume of 3.51 million shares and the average volume of the stock remained 708,657.00 shares. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinsons disease, and multiple sclerosis.
Why Should Investors Buy BCLI After The Recent Gain? Just Go Here and Find Out
Overseas Shipholding Group Inc.(OTCMKTS:OSGIQ) traded with volume of 252,329.00 shares in the prior session and the average volume of the stock remained 319,638.00 shares. The 52 week range of the stock remained $0.85 - $8.72. The stock showed a positive movement of +9.87% and closed its session at $8.68. The market capitalization of the stock remained 226.61 million. Overseas Shipholding Group, Inc. is engaged primarily in the ocean transportation of crude oil and petroleum products.
Will OSGIQ Continue To Move Higher? Find Out Here
IntelGenx Technologies Corp.(OTCMKTS:IGXT) exchanged 5.23 million shares and the average volume remained 1.12 million shares. The stock escalated +9.59% and closed the session at $0.800. The beta of the stock remained 32.25 and the EPS of the stock remained -0.03. The shares outstanding of the stock remained 51.30 million. IntelGenx Technologies Corp., a drug delivery company, engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
For How Long IGXT will fight for Profitability? Read This Trend Analysis report
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) gained volume of 626,827.00 shares, while the average volume remained 473,390.00 shares. The stock advanced +9.12% and finished the session Wednesday at $0.730. The EPS of the stock remained 0.13. The three month trend remained negative -13.1%. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
For How Long TTNP’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)